A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (CAAA601A22301)

Grants and Contracts Details

StatusFinished
Effective start/end date1/7/2211/2/22

Funding

  • Advanced Accelerator Applications SA: $21,031.00